Learning from HIV epidemics among injecting drug users

International Journal of Drug Policy

Volumn 21, Issue 2, 2010, Pages 97-99

  Jarlais, Don C Des ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Harm reduction; HIV AIDS; Injecting drug users; Policy

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; EPIDEMIC; EPIDEMIOLOGICAL DATA; ETHNIC GROUP; EVIDENCE BASED MEDICINE; HARM REDUCTION; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RIGHTS; INFECTION PREVENTION; INTRAVENOUS DRUG ABUSE; PRIORITY JOURNAL; PUBLIC HEALTH; SOCIAL PROBLEM; VIRUS TRANSMISSION;

EID: 77649342343     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2009.11.001     Document Type: Note

References (24)

1. Beyrer C., Razak M.H., Lisam K., Chen J., and Lui W. Overland heroin trafficking routes and HIV-1 spread in South and Southeast Asia. AIDS 17 1 (2000) 75-83
2. Centers for Disease Control and Prevention. CDC HIV/AIDS (2009), Department of Health and Human Services, Atlanta, GA
3. Choopanya K., Vanichseni S., Des Jarlais D.C., Plangsringarm K., Sonchai W., Carballo M., et al. Risk factors and HIV seropositivity among injecting drug users in Bangkok. AIDS 5 (1991) 1509-1513
4. Craib K.J., Spittal P.M., Wood E., Laliberte N., Hogg R.S., Li K., et al. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. Canadian Medical Association Journal 168 (2003) 19-24
5. Des Jarlais D.C., Friedman S.R., Novick D.M., Sotheran J.L., Thomas P., Yancovitz S., et al. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. Journal of the American Medical Association 261 (1989) 1008-1012
6. Des Jarlais D.C., Hagan H., Friedman S.R., Friedmann P., Goldberg D., Frischer M., et al. Maintaining low HIV seroprevalence in populations of injecting drug users. Journal Association Medical Association 274 15 (1995) 1226-1231
7. Des Jarlais D.C., Perlis T.P., Arasteh K., Torian L.V., Beatrice S., Milliken J., et al. HIV incidence among injection drug users in New York City, 1990 to 2002: Use of serologic test algorithm to assess expansion of HIV prevention services. American Journal of Public Health 95 8 (2005) 1439-1444
8. Des Jarlais D.C. Can HIV be eliminated among injecting drug users?. Presented at the 2009 national HIV prevention conference. Atlanta, GA, August 23-26 (2009)
9. Des Jarlais D.C., Arasteh A., Hagan H., McKnight C., Perlman D.C., and Friedman S.R. Persistence and change in disparities in HIV infection among injecting drug users in New York City after large-scale syringe exchange. American Journal of Public Health 99 Suppl. 2 (2009) S445-S451
10. Emmanuelli J., and Desenclos J.C. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003. Addiction 100 11 (2005) 1690-1700
11. Friedman T.L. The Lexus and the olive tree (2000), Anchor Books, New York
12. Hammett T.M., Wu Z., Duc T.T., Stephens D., Sullivan S., Liu W., et al. 'Social Evils' and harm reduction: The evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam. Addiction 103 (2007) 137-145
13. Hacker M.A., Leite I., Friedman S.R., Carrijo R.G., and Bastos F.I. Poverty, bridging between injecting drug users and the general population, and "interiorization" may explain the spread of HIV in southern Brazil. Health & Place 15 (2009) 514-519
14. Kabakchieva E., Vassileva S., Kelly J.A., Amirkhanian Y.A., DiFranceisco W.J., McAuliffe T.L., et al. HIV risk behavior patterns, predictors, and sexually transmitted disease prevalence in the social networks of young Roma (Gypsy) men in Sofia, Bulgaria. Sexually Transmitted Diseases 33 (2006) 485-490
15. Kaldor J., Elford J., Wodak A., Crofts J.N., and Kidd S. HIV prevalence among IDUs in Australia: A methodological review. Drug and Alcohol Review 12 (1993) 175-184
16. Omori K. Knowledge about AIDS and risk behaviors among hill tribes in northern Thailand. Nippon Koshu Eisei Zasshi 46 (1999) 466-475
17. Sanaullah F., Gillian M., and Lavin T.J. Screening of substance misuse during early pregnancy in Blyth: An anonymous unlinked study. Journal of Obstetrics and Gynaecology 26 3 (2006) 187-190
18. Stimson G.V. AIDS and injecting drug use in the United Kingdom, 1987-1993: The policy response and the prevention of the epidemic. Social Science & Medicine 41 5 (1995) 699-716
19. Stimson G.V., Adelekan M.L., and Rhodes T. The diffusion of drug injection in developing countries. International Journal of Drug Policy 7 (1996) 245-255
20. In: Stimson G.V., Des Jarlais D.C., and Ball A. (Eds). Drug injecting and HIV infection: Global dimensions and local responses (1998), UCL Press, London
21. Stimson G.V., Fitch C., Des Jarlais D.C., Poznyak V., Perlis T., Oppenheimer E., et al., WHO Phase II Drug Injection Collaborative Study Group. Rapid assessment and response studies of injection drug user: Knowledge gain, capacity building, and intervention development in a multisite study. American Journal of Public Health 96 (2006) 288-295
22. UNAIDS/WHO. AIDS epidemic update: December 2006 (2007), Joint United Nations Programme on HIV/AIDS, Geneva
23. Uüskula A., McNutt L.A., Dehovitz J., Fischer K., and Heimer R. High prevalence of blood-borne virus infections and high-risk behaviour among injecting drug users in Tallinn, Estonia. International Journal of STD and AIDS 18 (2007) 41-46
24. Zhang Y., Shan H., Trizzino J., Ruan Y., Beauchamp G., Masse B., et al. Demographic characteristics and risk behavior associated with HIV positive injecting drug users in Xinjiang, China. The Journal of Infection 54 (2007) 285-290